Serum cytokine profiling reveals different immune response patterns during general and severe Mycoplasma pneumoniae pneumonia
暂无分享,去创建一个
Deli Xin | Yanmei Dong | Bao-Ping Xu | Zhikun Zhang | Chunmei Jia | R. Wei | D. Shi | Rui-Jie Wan | Haiwei Dou | Peng Tu | Jing Li | Li-hua Ning | Dongmei Wang
[1] Deli Xin,et al. Cell damage and neutrophils promote the infection of Mycoplasma pneumoniae and inflammatory response. , 2022, Microbial pathogenesis.
[2] Jinyuan Y Fu,et al. Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in Mycoplasma pneumoniae pneumonia , 2022, Emerging microbes & infections.
[3] Chad W. MacPherson,et al. Probiotics Exhibit Strain-Specific Protective Effects in T84 Cells Challenged With Clostridioides difficile-Infected Fecal Water , 2022, Frontiers in Microbiology.
[4] Y. Yoshioka,et al. Neutrophil-Mediated Lung Injury Both via TLR2-Dependent Production of IL-1α and IL-12 p40, and TLR2-Independent CARDS Toxin after Mycoplasma pneumoniae Infection in Mice , 2021, Microbiology spectrum.
[5] Deli Xin,et al. Mechanism of Infantile Feire Kechuan Oral Solution against Mycoplasma pneumoniae infection of A549 cells. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[6] Xu Wang,et al. IL‐26 promotes the pathogenesis of malignant pleural effusion by enhancing CD4+IL‐22+ T‐cell differentiation and inhibiting CD8+ T‐cell cytotoxicity , 2021, Journal of leukocyte biology.
[7] Hua Peng,et al. LIGHT of pulmonary NKT cells annihilates tissue protective alveolar macrophages in augmenting severe influenza pneumonia. , 2021, Science bulletin.
[8] Yimou Wu,et al. Mycoplasma pneumoniae lipids license TLR‐4 for activation of NLRP3 inflammasome and autophagy to evoke a proinflammatory response , 2020, Clinical and experimental immunology.
[9] Zhengrong Chen,et al. The diagnostic value of serological tests and real-time polymerase chain reaction in children with acute Mycoplasma pneumoniae infection , 2020, Annals of translational medicine.
[10] Yuyun Li,et al. The clinical significance of IL-6 s and IL-27 s in Bronchoalveolar lavage fluids from children with mycoplasma pneumoniae pneumonia , 2019, BMC Infectious Diseases.
[11] M. Vargas,et al. Drastically elevated levels of Interleukin-6 and its soluble receptor complex in COVID-19 patients with acute respiratory distress , 2020, Clinical and Medical Investigations.
[12] G. Cheng,et al. Cytokine signatures associate with disease severity in children with Mycoplasma pneumoniae pneumonia , 2019, Scientific Reports.
[13] Dan Li,et al. Allele-specific real-time PCR testing for minor macrolide-resistant Mycoplasma Pneumoniae , 2019, BMC Infectious Diseases.
[14] T. Aune,et al. Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis. , 2019, The Journal of investigative dermatology.
[15] G. Ma,et al. HDAC5 promotes Mycoplasma pneumoniae‐induced inflammation in macrophages through NF‐&kgr;B activation☆ , 2019, Life sciences.
[16] R. Hendriks,et al. Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae , 2018, Infection and Immunity.
[17] Q. Shu,et al. Mycoplasma pneumoniae induces allergy by producing P1-specific immunoglobulin E. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[18] G. Cheng,et al. Interleukin 17A as a good predictor of the severity of Mycoplasma pneumoniae pneumonia in children , 2017, Scientific Reports.
[19] S. Holland,et al. A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis , 2017, The Journal of experimental medicine.
[20] Jianming Zhou,et al. Utility of Assessing Cytokine Levels for the Differential Diagnosis of Pneumonia in a Pediatric Population* , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[21] G. Cheng,et al. Transcriptome analysis of bronchoalveolar lavage fluid from children with severe Mycoplasma pneumoniae pneumonia reveals novel gene expression and immunodeficiency , 2017, Human Genomics.
[22] Zhimin Chen,et al. Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children , 2016, Scientific Reports.
[23] Yimou Wu,et al. Insights into the pathogenesis of Mycoplasma pneumoniae , 2016, Molecular medicine reports.
[24] T. Kishaba. Community-Acquired Pneumonia Caused by Mycoplasma pneumoniae: How Physical and Radiological Examination Contribute to Successful Diagnosis , 2016, Front. Med..
[25] Takashi Shimizu. Inflammation-inducing Factors of Mycoplasma pneumoniae , 2016, Front. Microbiol..
[26] Tingting Wang,et al. Imbalance of peripheral blood Th17 and Treg responses in children with refractory Mycoplasma pneumoniae pneumonia. , 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[27] R. Dumke,et al. Antibody Response to Mycoplasma pneumoniae: Protection of Host and Influence on Outbreaks? , 2016, Front. Microbiol..
[28] Zhengrong Chen,et al. Role of the Mycoplasma pneumoniae/Interleukin-8/Neutrophil Axis in the Pathogenesis of Pneumonia , 2016, PloS one.
[29] Zhimin Chen,et al. Altered cytokine levels in bronchoalveolar lavage fluids from patients with mycoplasma pneumonia infection , 2016 .
[30] M. Croft,et al. Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis. , 2015, The Journal of allergy and clinical immunology.
[31] Zhi-min Chen,et al. Increased T cell activation in BALF from children with Mycoplasma pneumoniae pneumonia , 2015, Pediatric pulmonology.
[32] Zhengrong Chen,et al. Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[33] K. Nakata,et al. Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications , 2014, Front. Microbiol..
[34] Rachelle W Johnson,et al. The Primary Function of gp130 Signaling in Osteoblasts Is To Maintain Bone Formation and Strength, Rather Than Promote Osteoclast Formation , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[35] A. Baker,et al. N-Terminal Truncated Intracellular Matrix Metalloproteinase-2 Induces Cardiomyocyte Hypertrophy, Inflammation and Systolic Heart Failure , 2013, PloS one.
[36] M. Kaplan,et al. Innate Stat3-mediated induction of the antimicrobial protein Reg3γ is required for host defense against MRSA pneumonia , 2013, The Journal of experimental medicine.
[37] M. Audran,et al. IL-26 Is Overexpressed in Rheumatoid Arthritis and Induces Proinflammatory Cytokine Production and Th17 Cell Generation , 2012, PLoS biology.
[38] O. Polašek,et al. Mycoplasma pneumoniae in adult community-acquired pneumonia increases matrix metalloproteinase-9 serum level and induces its gene expression in peripheral blood mononuclear cells , 2012, Medical science monitor : international medical journal of experimental and clinical research.
[39] A. Meryk,et al. Cutting Edge: Inhibition of IL-6 Trans-Signaling Protects from Malaria-Induced Lethality in Mice , 2012, The Journal of Immunology.
[40] S. Kamiya,et al. Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model. , 2011, Results in immunology.
[41] Mingjie Ding,et al. [Th1/Th2 immune response in bronchoalveolar lavage fluid in children with severe Mycoplasma pneumoniae pneumonia]. , 2011, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.
[42] Ning Li,et al. Distribution of Tuvaella brachiopod fauna and its tectonic significance , 2011 .
[43] D. Chaplin,et al. Critical Role of Macrophages and Their Activation via MyD88-NFκB Signaling in Lung Innate Immunity to Mycoplasma pneumoniae , 2010, PloS one.
[44] T. van der Poll,et al. Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia , 2010, European Respiratory Journal.
[45] M. Narita. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia , 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[46] M. Morozumi,et al. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia , 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[47] B. Lambrecht,et al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets , 2007, Nature Medicine.
[48] 清水 隆. A dipalmitoylated lipoprotein from Mycoplasma pneumoniae activates NF-κB through TLR1, TLR2, and TLR6 , 2006 .
[49] D. Lawrence,et al. TWEAK Attenuates the Transition from Innate to Adaptive Immunity , 2005, Cell.
[50] Takashi Shimizu,et al. A Dipalmitoylated Lipoprotein from Mycoplasma pneumoniae Activates NF-κB through TLR1, TLR2, and TLR61 , 2005, The Journal of Immunology.
[51] K. Hoek,et al. A role for the Mycoplasma pneumoniae adhesin P1 in interleukin (IL)-4 synthesis and release from rodent mast cells. , 2005, Microbial pathogenesis.
[52] Ken B. Waites,et al. Mycoplasma pneumoniae and Its Role as a Human Pathogen , 2004, Clinical Microbiology Reviews.
[53] D. Talkington,et al. Cytokines in Mycoplasma pneumoniae infections. , 2004, Cytokine & growth factor reviews.
[54] K. Waites. New concepts of Mycoplasma pneumoniae infections in children , 2003, Pediatric pulmonology.
[55] M. Rincón,et al. The two faces of IL-6 on Th1/Th2 differentiation. , 2002, Molecular immunology.
[56] D. Talkington,et al. Regulation of Proinflammatory Cytokines in Human Lung Epithelial Cells Infected with Mycoplasma pneumoniae , 2002, Infection and Immunity.
[57] Mark A. Hall,et al. Interleukin-11 Signals through the Formation of a Hexameric Receptor Complex* , 2000, The Journal of Biological Chemistry.
[58] A. O’Regan,et al. Osteopontin augments CD3‐mediated interferon‐γ and CD40 ligand expression by T cells, which results in IL‐12 production from peripheral blood mononuclear cells , 2000, Journal of leukocyte biology.
[59] G. Biberfeld. Macrophage migration inhibition in response to experimental mycoplasma pneumoniae infection in the hamster , 1973, The Journal of Immunology.